Literature DB >> 26586244

Investigation of pepsin in tears of children with laryngopharyngeal reflux disease.

Giannicola Iannella1, Giovanni Di Nardo2, Rocco Plateroti3, Paolo Rossi4, Andrea Maria Plateroti5, Paola Mariani6, Giuseppe Magliulo7.   

Abstract

OBJECTIVES: Numerous investigations postulated that laryngopharyngeal reflux (LPR) is implicated in the pathogenesis of various upper airway inflammatory diseases as sinusitis or dacryostenosis. The presence of pepsin in tears might be confirmed the presuntive hypothesis of the arrival in the nasolacrimal ducts and precorneal tears film through the laryngopharyngeal reflux of either gastric acid or stomach secretions (pepsin) with inflammatory potentialities. The aim of this preliminary study was to identify the presence or absence of pepsin in the tears collected from children with a high suspicion of LPR who underwent 24-h pH (MII-pH) monitoring to confirm the disease.
METHODS: This study enrolled 20 patients suffering from symptoms of laryngopharyngeal reflux that underwent 24-h multichannel intraluminal impedance (MII)-pH monitoring to confirm the disease. The findings of the study group were compared with those of a control group of patients with negative pH monitoring. The quantitative analysis of human pepsin concentration in the tear samples was performed by ELISA method in both groups.
RESULTS: Four children (20%) of the study group showed pepsin in the tears. All of the subjects belonging to the control group were negative for its presence. No difference differences in the total number of reflux episodes and the number of weakly basic reflux in the pepsin positive patients vs. pepsin negative children were present.
CONCLUSIONS: 20% of the children with diagnosed LPR showed pepsin in the tears. Our specific investigation might provide information regarding sinusitis or dacryostenosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Gastroesophageal reflux; Laryngopharyngeal reflux; Pediatric; Pepsin; Tears; pH-metry

Mesh:

Substances:

Year:  2015        PMID: 26586244     DOI: 10.1016/j.ijporl.2015.10.034

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  8 in total

1.  Eye reflux: an ocular extraesophageal manifestation of gastric reflux.

Authors:  Danilo Mazzacane; Valerio Damiani; Michela Silvestri; Giorgio Ciprandi; Pierfranco Marino
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

Review 2.  Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis.

Authors:  Jing Wang; Yu Zhao; Jianjun Ren; Yang Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-13       Impact factor: 2.503

3.  Laryngopharyngeal Reflux Diagnosis in Obstructive Sleep Apnea Patients Using the Pepsin Salivary Test.

Authors:  Giannicola Iannella; Claudio Vicini; Antonella Polimeni; Antonio Greco; Riccardo Gobbi; Filippo Montevecchi; Andrea De Vito; Giuseppe Meccariello; Giovanni Cammaroto; Giovanni D'Agostino; Annalisa Pace; Raffaella Cascella; Marco Brunori; Cristina Anna Maria Lo Iacono; Stefano Pelucchi; Giuseppe Magliulo
Journal:  Int J Environ Res Public Health       Date:  2019-06-10       Impact factor: 3.390

4.  Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Authors:  Peter William Dettmar; Andrew David Woodcock; Matthew David Wilcox; Peter Ian Chater; Jeffrey Peter Pearson
Journal:  Aliment Pharmacol Ther       Date:  2019-05       Impact factor: 8.171

5.  The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.

Authors:  Zihao Guo; Yanhong Wu; Jing Chen; Shutian Zhang; Chuan Zhang
Journal:  Med Sci Monit       Date:  2020-11-21

6.  Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.

Authors:  Rocco Plateroti; Marta Sacchetti; Giuseppe Magliulo; Andrea Maria Plateroti; Annalisa Pace; Antonietta Moramarco; Alessandro Lambiase; Alice Bruscolini
Journal:  Life (Basel)       Date:  2020-09-15

7.  Awareness about laryngopharyngeal reflux disease among Chinese otolaryngologists: a nationwide survey.

Authors:  Shuifang Xiao; Jinrang Li; Hongliang Zheng; Xiangping Li; Hui Yang; Junbo Zhang; Xiaoxia Peng; Shuihong Zhou; Chen Zhao; Donghui Chen; Xuping Xiao; Li Shi; Hui Huangfu; Zhenfeng Tao; Xiong Chen; Yehai Liu; Shenhong Qu; Guangke Wang; Ting Chen; Xiaobo Cui; Linli Tian; Wensheng Zhou; Hongyan Fang; Yongwang Huang; Guodong Yu; Zhenqun Lin; Liang Tang; Jian He; Ruixia Ma; Zhaoyan Yu
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

8.  Obstructive sleep apnoea patients vs laryngopharyngeal reflux disease: Non-invasive evaluation with NBI and pepsin detection in tears.

Authors:  Annalisa Pace; Valeria Rossetti; Alessandro Milani; Giannicola Iannella; Salvatore Cocuzza; Antonino Maniaci; Danilo Alunni Fegatelli; Annarita Vestri; Antonio Greco; Marco De Vincentiis; Francesca Giovannetti; Rocco Plateroti; Giuseppe Magliulo
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.